Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W168593554', 'doi': 'https://doi.org/10.1016/s0193-953x(18)30744-5', 'title': 'Movement Disorders with Neuroleptic Drug Treatment', 'display_name': 'Movement Disorders with Neuroleptic Drug Treatment', 'publication_year': 1984, 'publication_date': '1984-09-01', 'ids': {'openalex': 'https://openalex.org/W168593554', 'doi': 'https://doi.org/10.1016/s0193-953x(18)30744-5', 'mag': '168593554', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/6148742'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0193-953x(18)30744-5', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121233926', 'display_name': 'Psychiatric Clinics of North America', 'issn_l': '0193-953X', 'issn': ['0193-953X', '1558-3147'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5072390302', 'display_name': 'Daniel Tarsy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I136199984', 'display_name': 'Harvard University', 'ror': 'https://ror.org/03vek6s52', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I136199984']}, {'id': 'https://openalex.org/I4210092960', 'display_name': 'Deaconess Hospital', 'ror': 'https://ror.org/00h2bj464', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210092960']}, {'id': 'https://openalex.org/I111088046', 'display_name': 'Boston University', 'ror': 'https://ror.org/05qwgg493', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I111088046']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Daniel Tarsy', 'raw_affiliation_strings': ['Departments of Neurology, Boston University School of Medicine and Harvard Medical School, Boston, Massachusetts', 'Section of Neurology, New England Deaconess Hospital'], 'affiliations': [{'raw_affiliation_string': 'Departments of Neurology, Boston University School of Medicine and Harvard Medical School, Boston, Massachusetts', 'institution_ids': ['https://openalex.org/I136199984', 'https://openalex.org/I111088046']}, {'raw_affiliation_string': 'Section of Neurology, New England Deaconess Hospital', 'institution_ids': ['https://openalex.org/I4210092960']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5072390302'], 'corresponding_institution_ids': ['https://openalex.org/I136199984', 'https://openalex.org/I4210092960', 'https://openalex.org/I111088046'], 'apc_list': None, 'apc_paid': None, 'fwci': 2.288, 'has_fulltext': False, 'cited_by_count': 33, 'citation_normalized_percentile': {'value': 0.836436, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '7', 'issue': '3', 'first_page': '453', 'last_page': '471'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11921', 'display_name': 'Efficacy and Safety of Electroconvulsive Therapy', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11921', 'display_name': 'Efficacy and Safety of Electroconvulsive Therapy', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T14286', 'display_name': 'Postural Deformities in Neurological Disorders', 'score': 0.9877, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12082', 'display_name': 'Pathophysiology and Clinical Characteristics of Stress-Induced Cardiomyopathy', 'score': 0.9729, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tardive-dyskinesia', 'display_name': 'Tardive dyskinesia', 'score': 0.9479456}, {'id': 'https://openalex.org/keywords/akathisia', 'display_name': 'Akathisia', 'score': 0.9245335}, {'id': 'https://openalex.org/keywords/movement-disorders', 'display_name': 'Movement disorders', 'score': 0.6998976}, {'id': 'https://openalex.org/keywords/antipsychotic-drug', 'display_name': 'Antipsychotic drug', 'score': 0.60395896}, {'id': 'https://openalex.org/keywords/neuroleptic-malignant-syndrome', 'display_name': 'Neuroleptic Malignant Syndrome', 'score': 0.473143}, {'id': 'https://openalex.org/keywords/tetrabenazine', 'display_name': 'Tetrabenazine', 'score': 0.4674215}, {'id': 'https://openalex.org/keywords/pathophysiology', 'display_name': 'Pathophysiology', 'score': 0.41455927}], 'concepts': [{'id': 'https://openalex.org/C2779158372', 'wikidata': 'https://www.wikidata.org/wiki/Q1546328', 'display_name': 'Tardive dyskinesia', 'level': 3, 'score': 0.9479456}, {'id': 'https://openalex.org/C2777393122', 'wikidata': 'https://www.wikidata.org/wiki/Q416417', 'display_name': 'Akathisia', 'level': 4, 'score': 0.9245335}, {'id': 'https://openalex.org/C2776525014', 'wikidata': 'https://www.wikidata.org/wiki/Q1531991', 'display_name': 'Parkinsonism', 'level': 3, 'score': 0.82435906}, {'id': 'https://openalex.org/C2780405171', 'wikidata': 'https://www.wikidata.org/wiki/Q629444', 'display_name': 'Dyskinesia', 'level': 4, 'score': 0.76212406}, {'id': 'https://openalex.org/C2780494398', 'wikidata': 'https://www.wikidata.org/wiki/Q208144', 'display_name': 'Antipsychotic', 'level': 3, 'score': 0.75540197}, {'id': 'https://openalex.org/C2778261627', 'wikidata': 'https://www.wikidata.org/wiki/Q2608695', 'display_name': 'Movement disorders', 'level': 3, 'score': 0.6998976}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6846517}, {'id': 'https://openalex.org/C3019878999', 'wikidata': 'https://www.wikidata.org/wiki/Q208144', 'display_name': 'Antipsychotic drug', 'level': 4, 'score': 0.60395896}, {'id': 'https://openalex.org/C2777964233', 'wikidata': 'https://www.wikidata.org/wiki/Q1424956', 'display_name': 'Neuroleptic malignant syndrome', 'level': 2, 'score': 0.56581634}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.49165326}, {'id': 'https://openalex.org/C2776284327', 'wikidata': 'https://www.wikidata.org/wiki/Q413050', 'display_name': 'Tetrabenazine', 'level': 3, 'score': 0.4674215}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.43147704}, {'id': 'https://openalex.org/C10162356', 'wikidata': 'https://www.wikidata.org/wiki/Q1135939', 'display_name': 'Pathophysiology', 'level': 2, 'score': 0.41455927}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.24400851}, {'id': 'https://openalex.org/C187212893', 'wikidata': 'https://www.wikidata.org/wiki/Q123028', 'display_name': 'Pediatrics', 'level': 1, 'score': 0.24177861}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.17562988}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.1174393}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.11096823}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.10154605}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D001480', 'descriptor_name': 'Basal Ganglia Diseases', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': True}, {'descriptor_ui': 'D000208', 'descriptor_name': 'Acute Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017109', 'descriptor_name': 'Akathisia, Drug-Induced', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001480', 'descriptor_name': 'Basal Ganglia Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003937', 'descriptor_name': 'Diagnosis, Differential', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004298', 'descriptor_name': 'Dopamine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D004298', 'descriptor_name': 'Dopamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018492', 'descriptor_name': 'Dopamine Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004409', 'descriptor_name': 'Dyskinesia, Drug-Induced', 'qualifier_ui': 'Q000628', 'qualifier_name': 'therapy', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006816', 'descriptor_name': 'Huntington Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006816', 'descriptor_name': 'Huntington Disease', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D009459', 'descriptor_name': 'Neuroleptic Malignant Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009459', 'descriptor_name': 'Neuroleptic Malignant Syndrome', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D010276', 'descriptor_name': 'Parasympatholytics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010276', 'descriptor_name': 'Parasympatholytics', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010302', 'descriptor_name': 'Parkinson Disease, Secondary', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010302', 'descriptor_name': 'Parkinson Disease, Secondary', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D011954', 'descriptor_name': 'Receptors, Dopamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011954', 'descriptor_name': 'Receptors, Dopamine', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005879', 'descriptor_name': 'Tourette Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005879', 'descriptor_name': 'Tourette Syndrome', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0193-953x(18)30744-5', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121233926', 'display_name': 'Psychiatric Clinics of North America', 'issn_l': '0193-953X', 'issn': ['0193-953X', '1558-3147'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/6148742', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 39, 'referenced_works': ['https://openalex.org/W1998201879', 'https://openalex.org/W1998773676', 'https://openalex.org/W2002339806', 'https://openalex.org/W2006664392', 'https://openalex.org/W2014059480', 'https://openalex.org/W2018287375', 'https://openalex.org/W2019906339', 'https://openalex.org/W2025924280', 'https://openalex.org/W2027891315', 'https://openalex.org/W2030901186', 'https://openalex.org/W2043778391', 'https://openalex.org/W2047448707', 'https://openalex.org/W2047854031', 'https://openalex.org/W2051153443', 'https://openalex.org/W2055071717', 'https://openalex.org/W2061852415', 'https://openalex.org/W2061952196', 'https://openalex.org/W2064678384', 'https://openalex.org/W2068827025', 'https://openalex.org/W2069837065', 'https://openalex.org/W2076529413', 'https://openalex.org/W2080680105', 'https://openalex.org/W2084186988', 'https://openalex.org/W208632861', 'https://openalex.org/W2093428090', 'https://openalex.org/W2112450776', 'https://openalex.org/W2123405304', 'https://openalex.org/W2135018536', 'https://openalex.org/W2151872428', 'https://openalex.org/W2152289283', 'https://openalex.org/W2163554652', 'https://openalex.org/W2166985552', 'https://openalex.org/W2308811344', 'https://openalex.org/W2396384744', 'https://openalex.org/W2462538025', 'https://openalex.org/W4236721123', 'https://openalex.org/W4247139476', 'https://openalex.org/W4256192606', 'https://openalex.org/W597196858'], 'related_works': ['https://openalex.org/W4245315862', 'https://openalex.org/W4205764559', 'https://openalex.org/W2794300209', 'https://openalex.org/W2417259952', 'https://openalex.org/W2313464899', 'https://openalex.org/W2226687450', 'https://openalex.org/W2123616451', 'https://openalex.org/W2065803662', 'https://openalex.org/W2023069876', 'https://openalex.org/W1981200642'], 'abstract_inverted_index': {'Antipsychotic': [0], 'drugs': [1], 'produce': [2], 'several': [3], 'neurologic': [4], 'complications': [5], 'including': [6], 'acute': [7], 'dyskinesia,': [8], 'parkinsonism,': [9], 'neuroleptic': [10], 'malignant': [11], 'syndrome,': [12], 'akathisia,': [13], 'and': [14, 39], 'tardive': [15], 'dyskinesia.': [16], 'Despite': [17], 'increased': [18], 'awareness': [19], 'of': [20, 41], 'these': [21, 42], 'syndromes,': [22], 'they': [23], 'continue': [24], 'to': [25], 'be': [26], 'underdiagnosed': [27], 'among': [28], 'patients': [29], 'receiving': [30], 'antipsychotic': [31], 'drugs.': [32], 'The': [33], 'clinical': [34], 'features,': [35], 'possible': [36], 'pathophysiologic': [37], 'mechanisms,': [38], 'treatment': [40], 'conditions': [43], 'are': [44], 'discussed': [45], 'in': [46], 'this': [47], 'review.': [48]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W168593554', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-08-31T13:43:01.591357', 'created_date': '2016-06-24'}